Drug Evaluation

Home
About
Help
History (1)
- Drug Evaluation
- See All Pages

"Drug Evaluation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals.

Descriptor ID	D004341
MeSH Number(s)	E05.337.425
Concept/Terms	Drug Evaluation Drug Evaluation Drug Evaluations Evaluation, Drug Evaluations, Drug Evaluation Studies, Drug Drug Evaluation Studies Drug Evaluation Study Evaluation Study, Drug Studies, Drug Evaluation Study, Drug Evaluation

Below are MeSH descriptors whose meaning is more general than "Drug Evaluation".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Investigative Techniques [E05]
Evaluation Studies as Topic [E05.337]
Drug Evaluation [E05.337.425]

Below are MeSH descriptors whose meaning is related to "Drug Evaluation".

Below are MeSH descriptors whose meaning is more specific than "Drug Evaluation".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Evaluation" by people in this website by year, and whether "Drug Evaluation" was a major or minor topic of these publications.

Bar chart showing 14 publications over 10 distinct years, with a maximum of 3 publications in 1998

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	1	1
1998	1	2	3
2001	0	1	1
2003	1	0	1
2004	1	1	2
2005	0	1	1
2007	1	1	2
2011	1	0	1
2016	1	0	1
2017	0	1	1

Below are the most recent publications written about "Drug Evaluation" by people in Profiles.

Davis JM, El-Haj N, Shah NN, Schwartz G, Block M, Wall J, Tidswell M, DiNino E. Use of the blood substitute HBOC-201 in critically ill patients during sickle crisis: a three-case series. Transfusion. 2018 01; 58(1):132-137.

View in: PubMed
Fain KM, Yu T, Li T, Boyd CM, Singh S, Puhan MA. Evidence selection for a prescription drug's benefit-harm assessment: challenges and recommendations. J Clin Epidemiol. 2016 06; 74:151-7.

View in: PubMed
Marles RJ, Barrett ML, Barnes J, Chavez ML, Gardiner P, Ko R, Mahady GB, Low Dog T, Sarma ND, Giancaspro GI, Sharaf M, Griffiths J. United States pharmacopeia safety evaluation of spirulina. Crit Rev Food Sci Nutr. 2011 Aug; 51(7):593-604.

View in: PubMed
Mazor KM, Sabin JE, Boudreau D, Goodman MJ, Gurwitz JH, Herrinton LJ, Raebel MA, Roblin D, Smith DH, Meterko V, Platt R. Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans. Med Care. 2007 Oct; 45(10 Supl 2):S29-37.

View in: PubMed
Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, Friedman ES, Gelenberg AJ, Kocsis JH, Dunner DL, Dunlop BW, Hirschfeld RM, Rothschild AJ, Ferguson JM, Schatzberg AF, Zajecka JM, Pedersen R, Yan B, Ahmed S, Schmidt M, Ninan PT. The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases. Biol Psychiatry. 2007 Dec 15; 62(12):1371-9.

View in: PubMed
Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006 May 01; 59(9):829-35.

View in: PubMed
Gardner W, Lidz CW, Hartwig KC. Authors' reports about research integrity problems in clinical trials. Contemp Clin Trials. 2005 Apr; 26(2):244-51.

View in: PubMed
Seiter K, Liu D, Siddiqui AD, Lerner R, Nelson J, Ahmed T. Evaluation of temozolomide in patients with myelodysplastic syndrome. Leuk Lymphoma. 2004 Jun; 45(6):1209-14.

View in: PubMed
Kramer MS, Winokur A, Kelsey J, Preskorn SH, Rothschild AJ, Snavely D, Ghosh K, Ball WA, Reines SA, Munjack D, Apter JT, Cunningham L, Kling M, Bari M, Getson A, Lee Y. Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression. Neuropsychopharmacology. 2004 Feb; 29(2):385-92.

View in: PubMed
Gurwitz JH. Testing medications in children. N Engl J Med. 2003 Feb 20; 348(8):763-4; author reply 763-4.

View in: PubMed

People

Explore

Similar Concepts

Top Journals